A new integrated insulin pump-glucose monitor system has launched on the U.S. market. FDA approved Johnson & Johnson/Animas Corp.’s Vibe insulin pump and continuous glucose monitoring system for adult diabetics, the company announced Dec. 1.
Vibe is the first FDA-approved integrated system featuring DexCom Inc.’s G4Platinum sensing technology and it allows patients to view glucose data from the pump device itself– including highs, lows,...